Spectrum Health Regional Laboratory is not validated to perform Chlamydia and Gonococcus testing on pediatric patients under the age of 14 years old. Testing for these patients must be sent to a reference laboratory. Please order a Reference Miscellaneous Test (#LAB848) and indicate complete test name when ordering.
Effective immediately, Michigan Blood no longer provides 5-pack platelets and Spectrum Health Blood Bank has changed nomenclature for platelet units when they are ordered. In the past, platelets were ordered as a 5-pack which came from 5 separate donors and had a volume of 250 mL. Current process is one single unit of pheresed platelets which comes from a single donor. The volume is 250 mL, an equivalent volume as a 5-pack of pooled random donor platelets. The bonus is that there are now fewer donor exposures when transfusing a unit of platelets. The 5:5:1 ratio still applies for MTPs (massive transfusions).
Questions may be directed to the Blood Bank using the “Contact Us” link above.
Effective October 15th, 2017, all specimens collected for Blood Bank must have two signatures on the specimen written in ink that is resistant to smearing after a patient has been identified according to the Patient Identification Policy.
One of the two collectors/witnesses must be a lab staff member, unless specimen is collected in Spectrum Health Surgery, Infusion Center, Special Care Hospital, Cardiac Cath Lab Procedure Room, or a cord blood in Labor and Delivery. For Outpatients, the patient may serve as the witness and initial the tube label.
Effective September 12, 2016, Spectrum Health Regional Laboratory (SHRL) will update the methodology for Vitamin D 25 Hydroxy Level (25-OH Vitamin D) from LCMS (Liquid Chromatography-Mass Spectrometry) to automated immunoassay.
Effective June 1, 2016, Malaria testing will be updated. Recommended first line testing for suspected malaria is called Malaria Rapid Screen which is a combination of a rapid BinaxNow test in Hematology and a blood smear review in Microbiology. The BinaxNow test has a reported sensitivity of 97.7% and specificity of 94.2% for detection of P. falciparum species if a patient has a parasitemia level of over 5000 parasites/uL; sensitivity is lower for other malaria species. The BinaxNow test is not reported to cross react with babesia species. BinaxNow testing will be available for all shifts in Hematology at the Spectrum Health Regional Laboratory. The specimen requirements are unchanged from previous malaria testing. Previous test “Malaria Smear for Protozoa” will be discontinued.